Connect with us

Health

Benchmark Initiates Coverage of Vital Farms with Strong Buy Rating

Editorial

Published

on

Equities researchers at Benchmark have initiated coverage of shares for Vital Farms (NASDAQ: VITL) with a “buy” rating and a price target of $60.00. This target suggests a potential upside of approximately 86.45% from the company’s previous closing price, according to a report released on November 4, 2023.

The report is part of a broader trend among analysts regarding Vital Farms. On the same day, Telsey Advisory Group reaffirmed an “outperform” rating with a price target of $50.00. Additionally, Cowen maintained a “buy” rating, while DA Davidson raised their price target from $51.00 to $52.00 in a report published on August 11, 2023. Stifel Nicolaus also increased their target from $44.00 to $48.00, indicating a positive outlook for the stock.

According to MarketBeat.com, analysts have generally rated the stock favorably, with one analyst giving it a Strong Buy rating, twelve assigning a Buy rating, and one issuing a Hold rating. The consensus rating for Vital Farms stands at “Buy,” with an average price target of $51.70.

Recent Earnings and Financial Performance

Vital Farms recently reported its earnings results on November 4, 2023. The company achieved $0.36 earnings per share (EPS) for the quarter, exceeding the consensus estimate of $0.30 by $0.06. The firm reported a revenue of $198.94 million, surpassing expectations of $191.35 million. This performance marks a significant increase, with revenue rising by 37.2% compared to the same quarter last year.

The company’s return on equity stood at 20.19%, accompanied by a net margin of 8.50%. Looking ahead, Vital Farms has set its guidance for fiscal year 2025 at an EPS of $1.11.

Insider Transactions and Institutional Investor Activity

In related news, there have been notable insider transactions at Vital Farms. On August 22, 2023, insider Joanne Bal sold 4,796 shares at an average price of $50.95, totaling approximately $244,356.20. Following this sale, she retained 43,332 shares valued at about $2.2 million. Moreover, insider Matthew Ohayer sold 145,000 shares on September 2, 2023, for a total of $7,537,100.00.

In the past three months, insiders have sold a combined total of 411,163 shares, amounting to approximately $20.4 million. Currently, 21.30% of the stock is held by corporate insiders.

Several hedge funds have also adjusted their positions in Vital Farms. Exchange Traded Concepts LLC acquired a new position worth $28,000 in the third quarter. Caitong International Asset Management Co. Ltd increased its stake by 20,650.0%, now owning 1,660 shares valued at $51,000. US Bancorp DE and CWM LLC have also grown their holdings significantly in recent months.

With institutional investors holding approximately 98.59% of the shares, Vital Farms demonstrates strong support within the investment community. As the company continues to grow, analysts will likely keep a close eye on its performance and market trends.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms specializes in providing pasture-raised products, including shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company’s commitment to quality and sustainable practices has positioned it as a notable player in the food industry.

Our Editorial team doesn’t just report the news—we live it. Backed by years of frontline experience, we hunt down the facts, verify them to the letter, and deliver the stories that shape our world. Fueled by integrity and a keen eye for nuance, we tackle politics, culture, and technology with incisive analysis. When the headlines change by the minute, you can count on us to cut through the noise and serve you clarity on a silver platter.

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.